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When precursors are also regulators
As well as being the precursors of the triacylglycerols deposited as
fat in adipose tissue, long-chain fatty acids are one class of agents
that induce the differentiation of preadipocytes to adipocytes.
Adipose triglycerol stored in fat cells (adipocytes) is the
major energy reserve of higher animals and can be depos-
ited in huge amounts in humans when caloric intake
continually exceeds expenditure. Adipocytes presumably
emerged during evolution because their fat-storing
capacity allowed survival during periods of energy dep-
rivation or famine. In modern (particularly western)
societies, however, where survival depends on other fac-
tors, the availability of high-fat foods and a sedentary
lifestyle have led to a high incidence of obesity and its
accompanying health problems, notably cardiovascular
disease and noninsulin-dependent diabetes.
Although the etiology of obesity is complex, there is com-
pelling evidence for a substantial genetic component. This
view was recently reinforced by the cloning of the mutant'
gene responsible for obesity in a strain of genetically obese
mice [1]. The wild-type gene encodes a protein secreted
by adipocytes that is believed to act on the hypothalamus
as a negative feedback agent to suppress appetite, increase
energy expenditure and maintain hormonal balance in
rodents. The obese gene is highly conserved in the human
genome, suggesting that dysregulation or mutation of the
gene may also contribute to human obesity [1].
An increased capacity for fat storage results from the
expansion of the adipocyte population by differentiation
from preadipocytes. The availability of preadipocyte. cell
lines that can differentiate into adipocytes in culture has
allowed detailed analyses of the agents capable of inducing
preadipocyte differentiation, and has led to the discovery
of putative 'master regulators', that is, key transcription
factors, whose expression is sufficient to induce adipose
conversion. To fulfil their energy storage function, adipo-
cytes must either import or synthesize the long-chain
fatty acids used to fabricate triacylglycerol for intracellular
deposition. Recent studies suggest that long-chain fatty
acids themselves may also act as one of the agents induc-
ing preadipocyte differentiation by triggering the expres-
sion and/or activation of the master regulators, thereby
promoting expansion of the adipocyte population and of
fat storage.
External inducers are required in order to trigger the
differentiation of preadipocytes into adipocytes (reviewed
in [2]). Although insulin-like growth factor 1, glucocor-
ticoids and cyclic AMP (or a cyclic AMP phosphodi-
esterase inhibitor) are well-established inducers, fatty
acids and the peroxisome proliferators (agents that induce
peroxisome formation) have only recently come onto
the scene as activators of adipogenesis in preadipocytes
(Fig. 1). Both fatty acids and peroxisome proliferators are
amphipathic and have carboxyl groups, although their
other structural features are dissimilar. Nevertheless, it is
likely that fatty acids and peroxisome proliferators induce
adipocyte gene expression and differentiation by a com-
mon mechanism. Neither fatty acids nor peroxisome
proliferators stimulate full differentiation alone, but they
act synergistically with other external inducers to activate
the differentiation program.
Fig. 1. The exogenous inducers, second
messengers and pleiotropic transcrip-
tion factors implicated in adipocyte
differentiation. Physiological concen-
trations of retinoic acid have recently
been shown to stimulate adipocyte
differentiation through activation of
retinoic acid receptor a (RARa) [16].
For a more detailed discussion of these
inducers and second messenger
systems, see [2].
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How then do fatty acids and peroxisome proliferators
activate adipogenesis? Adipocyte differentiation undoubt-
edly involves transcriptional activation of the genes that
create and maintain the adipocyte phenotype. Our under-
standing of this process was recently advanced by the
cloning of two members of the peroxisome proliferator-
activated receptor (PPAR) gene family from mice, and by
functional studies that implicate these genes as master reg-
ulators of the differentiation process. One of these genes
encodes a nuclear hormone receptor, mPPARy2, which
binds to the adipocyte-specific enhancer of the gene for
422/aP2, a fatty-acid-binding protein expressed exclu-
sively in adipocytes, in the form of a heterodimer with
retinoid X receptor a (RXRa). Reports from Spiegel-
man's laboratory [3,4] reveal that mPPARy2 is virtually
identical to the previously cloned mPPARyl [5], except
for an additional amino-terminal 30 amino acids. The
structures of the PPARs are typical of other members of
the steroid/thyroid hormone receptor superfamily. Both
mPPARy isoforms seem to be expressed predominately
in white adipose tissue [3,6].
The mPPAR-y isoforms are known to activate the tran-
scription of genes for the adipocyte marker proteins 422/
aP2 and phosphoenolpyruvate carboxykinase (PEPCK)
through their binding to peroxisome proliferator res-
ponse elements (PPREs) in the enhancers of these genes.
As mPPARy2 is specifically activated by both fatty acids
and peroxisome proliferators, this also confers fatty-acid-
inducibility on the 422/aP2 and PEPCK genes. But
although peroxisome proliferators and fatty acids indir-
ectly activate the PPARs, they do not seem to serve as
ligands for these receptors. A physiological ligand(s) has
not yet been identified, and this remains an important
gap in our knowledge. The critical role of mPPAR-y2 in
adipose conversion has been shown by the forced expres-
sion of mPPARy2 (and probably also of mPPARyl) in
fibroblasts. Treatment of fibroblasts with an activator of
the receptor is sufficient to induce adipose conversion in
these cells [4].
The other member of the PPAR family that regulates
adipocyte gene expression is the fatty-acid-activated
receptor (FAAR; also called mNUC1), which is the
mouse homolog of the human NUC1. Grimaldi and
colleagues [7] recently cloned the gene for this nuclear
hormone receptor from a cDNA library derived from
fatty-acid-induced mouse Ob1771 preadipocyte cells, by
screening with a conserved PPAR nucleotide sequence.
They observed that FAAR is expressed in a variety of
lipogenic tissues (such as white adipose tissue, lung and
intestine, but not liver), as well as certain non-lipogenic
tissues (muscle, for example), and that, like other PPARs,
FAAR binds to PPREs as a heterodimer with members
of the RXR family. Like PPARy2 [3,8], expression of
FAAR in a fibroblastic cell line was found to confer
fatty-acid-responsiveness on two endogenous adipocyte
marker genes - those for the 422/aP2 fatty-acid-bind-
ing protein and a fatty acid transporter [7]. Thus, both
PPARy2 and FAAR can activate expression of adipocyte
genes when transfected into fibroblast cell lines. Unlike
mPPAR-y2, however, FAAR seems to be more potently
activated by fatty acids than by peroxisome proliferators,
and it has not yet been demonstrated to be sufficient to
induce adipose conversion [7].
The identification of two different PPAR-related tran-
scription factors - the mPPARy isoforms and FAAR
- that activate expression of adipocyte markers raises the
question of whether both function equally as modulators
of preadipocyte differentiation, or whether one is of
greater importance. The relative contributions of FAAR
and mPPAR'y2 might be evaluated by comparing the
kinetics of their expression during the course of differen-
tiation; this has provided equivocal results, however.
Whereas Tontonoz et al. [3] found that mPPARy2 was
expressed shortly after induction of differentiation of
3T3-L1 and 3T3-F442A cells (within 1-2 days), Amri et
al. [7] observed much later expression of mPPARy2 dur-
ing differentiation of Ob1771 cells. Similar discrepancies
were observed in the timing of expression of FAAR dur-
ing differentiation of these cell lines. These discrepancies
underscore the difficulty of generalizing results obtained
with different preadipocyte cell lines. Although these dif-
ferences may be due, in part, to the efficacy of the agents
used to induce differentiation, they are more likely to
reflect differences in the stage of adipocyte development
at which the different cell lines were arrested during
cloning. All the preadipocyte cell lines achieve the same
endpoint of terminal differentiation, but their entry points
into the adipocyte differentiation program probably dif-
fer. Furthermore, different inducers and regulatory genes
may be required to traverse the different stages of the
developmental program.
The role of peroxisome proliferators in regulating lipid
homeostasis is well established; they can induce differen-
tiation of adipocytes as well as increasing lipid catabolism,
depending upon the prevailing nutritional state. Indeed, a
subclass of peroxisome proliferators, the fibrates, was ini-
tially developed as blood lipid-lowering agents for treat-
ment of coronary heart disease. All of these agents
increase both the size and number of hepatic peroxi-
somes, and induce peroxisomal 13-oxidation of fatty acids
by activating transcription of the genes encoding acyl-
CoA oxidase and 3-keto thiolase. The promoters of
these genes contain PPREs to which PPARs bind, thus
enabling transcriptional control indirectly by peroxisome
proliferators and fatty acids.
The PPARs do not function alone to trigger adipocyte
differentiation. Compelling evidence shows that expres-
sion of a basic region/leucine zipper transcription factor,
C/EBPt (CCAAT/enhancer binding protein a), is also
essential for the process [2]. Transcription of the C/EBPot
gene is activated just before the coordinate expression of
a group of adipocyte genes, the proximal promoters of
which bind to, and are transactivated by, C/EBPot [9].
Definitive proof that this transcription factor is required
for adipocyte differentiation was obtained by expression
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to 'kick-start' their transcription. Maintenance of high
levels of C/EBPoa in terminally differentiated adipocytes
is achieved through autoactivation of the C/EBPc pro-
moter by C/EBPot [9,13]. As autoactivation is observed
with many transcription factors involved in differentia-
tion (such as MyoD), mPPARy2 may also maintain its
high level of expression through a positive feedback
mechanism. The results of Tontonoz et al. [4] suggest that
ectopic expression of C/EBPt in NIH 3T3 cells is suffi-
cient to induce expression of mPPARy2 and that ectopic
expression of mPPARy2 is sufficient to induce expres-
sion of C/EBPo. This suggests that, in addition to auto-
activation, these transcription factors may cross-activate
each other's expression, and thus enforce the maintenance
of the fully differentiated state after the inducers of differ-
entiation have disappeared. These concepts are illustrated
in Figure 2.
Fig. 2. Possible interactions between mPPARy2, C/EBPra and
their respective genes in the activation and maintenance of
adipocyte differentiation. Transcriptional auto- and cross-activa-
tion by mPPARy2 and C/EBPra are shown; question marks indi-
cate inferred, but not proven regulation. The blue arrow refers to
binding of PPAR and the red arrow to binding of C/EBPa to their
respective cis-regulatory elements.
of its antisense RNA, which blocked adipocyte gene
expression and the acquisition of the adipocyte pheno-
type [10]. Furthermore, premature induction of C/EBPoa
in 3T3-L1 preadipocytes using an inducible expression
vector was sufficient to activate the differentiation pro-
gram without external inducers [11]. Similarly, Freytag's
group [12] showed that ectopic expression of C/EBPot
was sufficient to induce adipose conversion in a variety of
fibroblast and preadipocyte cell lines, several of which
were not committed to the adipocyte lineage. These find-
ings imply that expression of C/EBPax is both necessary
and sufficient for adipocyte differentiation. C/EBPo null
gene knockout' mice have a phenotype consistent with
this hypothesis (G. Darlington, personal communication).
Tontonoz et al. [4], on the other hand, found that forced
expression of both C/EBPot and mPPARy2 in a fibro-
blast cell line was required in order to obtain maximal
adipocyte differentiation. The fact that expression of
either transcription factor alone caused little differentia-
tion suggests that C/EBPot and mPPARy2 act synergisti-
cally. Such a synergistic interaction would be consistent
with the presence of functional binding sites for both
C/EBPx and mPPARy2 within the 5' flanking regions
of at least two genes induced during adipocyte differenti-
ation, 422/aP2 [3] and PEPCK [8]. Perhaps mPPARy2-
mediated activation from the adipose-specific enhancers
along with C/EBPao-mediated transactivation is sufficient
Although the transcription factors C/EBPot and
mPPARy2 (and probably FAAR) are clearly involved in
the transcriptional activation of genes that lead to devel-
opment of the adipocyte phenotype, their roles in the
fully differentiated adipocyte remain uncertain. Recent
work with C/EBPxt suggests that it may be involved in
coordinating changes in adipocyte gene expression fol-
lowing differentiation in response to glucocorticoids and
insulin [14,15]; mPPAR-y2 and FAAR may also have
roles in fully differentiated adipocytes by mediating the
effects of fatty acids on adipocyte gene expression.
Substantial inroads have been made into our understand-
ing of adipocyte differentiation and metabolism. The
development of cell lines that differentiate into adipo-
cytes in culture has facilitated detailed analyses of agents
capable of inducing adipose conversion, and has led
to the discovery of putative master regulators, such as
C/EBPQo and mPPARy2 (and probably FAAR), whose
expression is sufficient to induce adipose conversion.
Future research should elucidate the mechanisms by
which the exogenous inducing agents activate expression
of these master regulators, and also how these regulators
interact to activate the transcription of genes that create
and maintain the adipocyte phenotype.
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